Post-earnings recap
Reported
Tue, Nov 7, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported an earnings per share of $1.34, exceeding expectations by over 20%. However, the stock fell by 1.9% on the day, indicating that investors may have been looking for additional information or guidance that was not provided in this report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.34 | N/A | +20.94% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.